Joseph Gut - thasso
Posted in New Research, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
May 22, 2020 – Host factors (i.e., disease phenotypes and/or predispositions) instead of viral genetic variation seem to impact more on sickness severity among Covid-19 patients, as indicated by an investigation from China. Scientists in Shanghai analyzed clinical, atomic, and immunological information from in excess of 300 individuals with affirmed Covid-19.
…
Joseph Gut - thasso
Posted in Genetic Predisposition, Genetic Susceptibility, New Research, On The Horizon, Personalized Medicine, Thasso Post, Theragenomic Medicine
No Comments ↓
May 07, 2020 – Abdominal aortic aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than normal. AAAs usually cause no symptoms, except during rupture.
…
Joseph Gut - thasso
Posted in New Research, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
May 03, 2020 – The world is desperate in the search for a treatment or better yet a vaccine in the Covid-19 pandemic. Slowly, there are some options emerging at least for the treatment of seriously ill Covid-19 patients. First of all, the American Food and Drug Administration just issued an emergency use authorization (EUA) for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
…
Joseph Gut - thasso
Posted in New Research, On The Horizon, Personalized Medicine, Personomics, Targeted Therapy, Thasso Post, Theragenomic Medicine
No Comments ↓
July 26, 2019 – “Blockchains for secure digitized medicine”. This is the title of a very interesting and important article in the Journal of Personalised Medine (JPM) as of May 28, 2019.
Blockchain as an emerging technology (particularly around the hype on Bitcoins) has been gaining in popularity,
…
Joseph Gut - thasso
Posted in Genetic Background, In The Press, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
…
Joseph Gut - thasso
Posted in On The Horizon, Personalized Medicine, Thasso Post, Theragenomics
No Comments ↓
June 22, 2014 – The individuum (i.e., patient) is the phenotype expert on her/his individualized form of proper disease she/he is suffering from. It is not her/his treating physician, it is not a regulatory person concerned with the safety and efficacy of the medication geared towards treating her/his condition,
…
Joseph Gut - thasso
Posted in Genetic Background, Genetic Predisposition, New Research, On The Horizon, Personalized Medicine, Thasso Post, Theragenomic Medicine
No Comments ↓
June 5, 2015 – This is an edited post based on a PRNewswire release (see here) which refers to the 2015 June 4th joint meeting of the U.S. Food and Drug Administration’s (FDA) joint meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee,
…
Joseph Gut - thasso
Posted in Clinical Development, Digital Health, Genetic Background, Genetic Predisposition, In The Press, Neue Forschung, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
June 13, 2019 – This is simply fascinating stuff. Researchers are testing neural networks that automatically combine portrait photos with genetic and phenotypic patient data in order to obtain definitive diagnosis of hereditary rare diseases, all with the help of artificial intelligence (AI).
…
Joseph Gut - thasso
Posted in Allelic Variant, Genetic Background, Genetic Predisposition, Genetic Susceptibility, New Research, On The Horizon, Thasso Post, Theragenomic Medicine
No Comments ↓
May 13, 2018 – Researchers have uncovered 17 genetic variants linked to different depression-related phenotypes in a large genome-wide association study, including variants near genes involved in neurotransmission and synapse function.
The first author of the study, David Howard, Center for Clinical Brain Sciences, University of Edinburgh,
…
Optional: Social Subscribe/Login
thasso: recent comments